Jeffrey S. Wolf is a Partner and Medical Advisor to the Maryland Development Center. He is also co-founder of the MDC portfolio company Sonasa Medical, Inc. Dr. Wolf is the co-inventor with Dr. Amal Isaiah and Dr. Stephen Restaino of the MDC Sonosa device for detecting, classifying, and treating Obstructive Sleep Apnea. He is co-inventor with Dr. Aldo Iacono, Dr. Rajabrata Sarkar, and Dr. Rasa Ghaffarian of the MDC EO2 Emergency Resuscitation device.

In addition to his responsibilities at MDC, Dr. Wolf is Professor and Medical Director as well as Associate Chair of Clinical Practice in the Department of Otorhinolaryngology-Head and Neck Surgery at the University of Maryland School of Medicine. He is also a member of the Program in Oncology at the University of Maryland School of Medicine.

Dr. Wolf received his MD at the University of Pennsylvania School of Medicine and did his residency in Otolaryngology at the University of Maryland Medical Center. He has been faculty at the University of Maryland since 2001. He is an active clinician in Otolaryngology and Head and Neck Oncology and has been recognized as a Baltimore, Washington D.C. and National Top Doctor. His areas of clinical expertise include head and neck cancer, sleep apnea, airway, and sinonasal disease. Dr. Wolf has been the principal investigator in funded research in basic science, clinical trials, and device development.

Highlighted Publications

Wolf, J.S., Li, G., Varadhachary, A., Petrak, K., Schneyer, M., Li, D., Ongkasuwan, J., Zhang, X., Taylor, R.J., Strome, S.E., O’Malley, Jr., B.W.: Oral Lactoferrin Results in T-cell Dependent Tumor Inhibition of Head and Neck Squamous Cell Carcinoma in vivo. Clinical Cancer Research; 2007:13:1601-10.

Taylor, R.J., Chiu, A.G., Palmer, J.N., Schofield, K., O’Malley, B.W., Wolf, J.S.: Informed Consent in Sinus Surgery: Link between Demographics and Patient Desires. Laryngoscope 2005: 115(5): 826-831.

Wolf, J.S., Chiu, A.G., Palmer, J.N., Schofield, K., O’Malley, B.W., Taylor, R.J.: Informed Consent in Endoscopic Sinus Surgery: The Patient Perspective. Laryngoscope 2005: 115(3):492-494.

Suntharalingam M., Kwok Y., Goloubeva O., Parekh A,. Taylor R., Wolf J. Zimrin A. Strome S. Ord R. Cullen KJ. Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck. International Journal of Radiation Oncology, Biology, Physics, 2012: 82 (1845-50).

Hatten, K., Morales, R.E., Wolf, J.S., Intraorbital Erosion of a malar implant resulting in mastication-induced vision changes, ENT Journal, 2012: 91:E23 (online).

Strongin A. Yovino S. Taylor R. Wolf J. Cullen K. Zimrin A. Strome S. Regine W. Suntharalingam M. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics, 2012: 82 :1823-30.

Voskens, C.J., Sewell, D., Hertzano, R., Desanto, J., Rollings, S., Lee, M., Taylor, R., Wolf, J., Suntharalingam, M., Gastman, B., Papadimitriou, J.C., Lu, C., Tan, R., Cullen, K., Celis, E., Mann, D., Strome, S.E. Induction of MAGE-A# and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma. Head & Neck, 2012: 34: 1734-46.

Zandberg, D.P., Liu, S., Goloubeva, O., Ord, R., Strome, S.E., Suntharalingam, M., Taylor, R., Morales, R.E., Wolf, J.S., Zimrin, A., Lubek, J.E., Schumaker, L.M., Cullen, K.J. Oropharyngeal Cancer (OPC) Drives Racial Outcome Disparities in Squamous Cell Carcinoma of the Head and Neck (HNSCC): Ten Year Experience at the University of Maryland Greenebaum Cancer Center (UMGCC). Head and Neck, 2015:38:564-72.

Zandberg, D.P., Rollings, S., Goloubeva, O., Morales, R.E., Tan, M., Taylor, R., Wolf, J.S., Schumaker, L.M., Cullen, K.J., Zimrin, A., Ord, R., Lubek, J.E., Suntharalingam, M., Papadimitriou, J.C. Mann, D., Strome, S.E., Edelman, M.J. A Phase I Dose Escalation Trial of MAGE-A3 and HPV16 Specific Peptide Immunomodulatory Vaccines in Patients with Recurrent / Metastatic (RM) Squamous Cell Carcinoma of the Head and Neck (SCCHN). Cancer Immunology, Immunotherapy, 2015: 64:367-379.

Patents

Techniques for Emergency Apneic Oxygenation PCT/US2013/051739

Ultrasound Localization of Obstruction for Obstructive Sleep Apnea PCT/US2015/01349

System and Method for Emergency Apneic Oxygenation PCT/US/2015/012465 (CIP)

Apparatus and Method for Placement of Device along Wall of a Body Lumen PCT/US2016/033917

Apparatus and Method for Placement of Device along theWall of a Body Lumen (CIP) PCT/US/2016/063495

Automatic Ultrasound Titration of Continuous Positive Airway Pressure (CPAP) Treatment for Sleep Apnea US Provisional Patent Application: 62/291,937

Automated Emergency Airway Ventilation Device US Provisional Patent Application: 62/333,299

Detachable Optical Extension Apparatus US Provisional Patent Application: 62/340,601

Awards

2010 Baltimore Magazine “Top Doc” for Otolaryngology

2010 Baltimore Magazine “Top Doc” for Head and Neck Oncology

2011 Washington, DC-Baltimore “Super Doctors”

2011 US News “Top Doc”

2011 Castle-Connolly “Top Doc”

2012 Washington, DC-Baltimore “Super Doctors”

2012 Castle-Connolly “Top Doc”

2012 US News “Top Doc”

2012 Baltimore Magazine “Top Doc” for Otolaryngology

2012 Baltimore Magazine “Top Doc” for Head and Neck Oncology

2012 University of Maryland Otolaryngology Outstanding Teaching Award

2013 Washington, DC-Baltimore “Super Doctors”

2013 Castle-Connolly “Top Doc”

2013 US News “Top Doc”

2014 Castle-Connolly “Top Doc”

2014 Baltimore Magazine “Top Doc” for Otolaryngology

2014 Baltimore Magazine “Top Doc” for Head and Neck Oncology

2015 Castle-Connolly “Top Doc”

2016 Castle-Connolly “Top Doc”

2016 Baltimore Magazine “Top Doc” for Otolaryngology

2016 University of Maryland Otolaryngology Outstanding Teaching Award